Market Place
Sourcing Support
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Novel Labs` Generic Fluocinolone Acetonide Receives Approval in the U.S.
07 Aug 2023 //
FDA
Alimera Announces Submission of MAA in Switzerland for ILUVIEN
22 Feb 2023 //
GLOBENEWSWIRE
Paladin Phase 4 Study Confirms ILUVIEN® Patients`
06 Oct 2022 //
GLOBENEWSWIRE
Alimera Announces Agreement with Jaeb Center for Health Research on Behalf
23 Sep 2022 //
GLOBENEWSWIRE
Alimera Announces Multiple Abstracts Highlighting ILUVIEN® Real World Data
31 Aug 2022 //
GLOBENEWSWIRE
Researchers Compare Intravitreal Implants for Non-Infectious Posterior Uveitis
11 May 2021 //
HCPLIVE
Alimera Announces Posters and Papers Highlighting the Durability of ILUVIEN
23 Sep 2020 //
GLOBENEWSWIRE
Alimera Science Announces Enrollment of Patient in Clinical Trial of ILUVIEN
01 Sep 2020 //
GLOBENEWSWIRE
EyePoint Pharmaceuticals Presents Data Supporting YUTIQ® at t (ASRS)
27 Jul 2020 //
EYEPOINTPHARMA
Alimera Sciences Initiates Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN®
09 Jul 2020 //
GLOBENEWSWIRE
Building on successful PD-1 pact, Eli Lilly licenses diabetes drug to Chinese
23 Aug 2019 //
ENDPTS
TGA approves new drug for diabetes induced vision loss
05 Aug 2019 //
BIOSPECTRUMASIA
Encube Ethicals`s Generic Fluocinolone Acetonide Receives Approval in US
13 Feb 2019 //
FDA
G And W Labs Inc`s Generic Fluocinolone Acetonide Receives Approval in US
08 Nov 2018 //
FDA
FDA Action Alert: EyePoint Pharma and Merck
05 Nov 2018 //
BIOSPACE
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Glenmark Pharms` Generic Fluocinolone Acetonide Receives Approval in US
27 Oct 2018 //
FDA
Laboratorios Salvat completes patient recruitment for the CIFLOTEX trial
12 Sep 2018 //
PRESS RELEASE
Enforcement Report - Week of July 18, 2018
18 Jul 2018 //
FDA
Plan and plan some more: Alimera’s recipe for social success
23 May 2018 //
FIERCE PHARMA
Enforcement Report - Week of May 2, 2018
02 May 2018 //
FDA
Patrin Pharma’s Generic Fluocinolone Acetonide Receives Approval In US
14 Apr 2018 //
FDA
Novartis backs eye drop maker in $20M round, meds to fill gap left by Eylea
04 Jan 2018 //
END POINTS
Glasshouse Pharm’s Generic Fluocinolone Acetonide Receives Approval In US
28 Dec 2017 //
FDA
Perrigo Israel’s Generic Fluocinolone Acetonide Receives Approval In US
18 Jul 2017 //
FDA
Perrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS
21 Jun 2017 //
PR NEWSWIRE
Pediapharm Announces the Commercial Launch of Otixal™ in Canada
18 May 2017 //
PRESS RELEASE
Actavis`s Generic Fluocinolone Acetonide Approved In US
21 Oct 2016 //
FDA
Versapharm`s Generic Fluocinolone Acetonide Approved In US
09 Sep 2016 //
FDA
Laboratorios SALVAT & Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL
29 Aug 2016 //
PR NEWSWIRE
Salvat, Lee`s Pharma Ltd Announce Exclusive License,Supply Agreement for Duoxal®
11 Jan 2016 //
PR NEWS WIRE
Alimera Sciences Signs Agreement To Distribute ILUVIEN® In The Middle East
15 Dec 2015 //
PR NEWS WIRE
Alimera Sciences announces late breaking presentation of new ILUVIEN Analysis
04 Nov 2015 //
PR NEWS WIRE
pSivida Corp. Reports ILUVIEN® for DME Approved in Poland
14 Apr 2015 //
PSIVIDA
FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco
11 Mar 2015 //
RAPS
Alimera Sciences Announces First Sale of ILUVIEN in Portugal
14 Jan 2015 //
ALIMERA SCIENCES
